The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men

BACKGROUND: Mirabegron is a β3-adrenoreceptor agonist developed for treatment of overactive bladder (OAB). α1-Adrenergic receptor blockers are effective for lower urinary tract symptoms (LUTS) in male patients. However, the efficacy of mirabegron additional treatment in elderly male patients with pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Tomohiro, Miyata, Yasuyoshi, Kakoki, Katsura, Yuzuriha, Miki, Asai, Akihiro, Ohba, Kojiro, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966767/
https://www.ncbi.nlm.nih.gov/pubmed/27473059
http://dx.doi.org/10.1186/s12894-016-0165-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966767/
https://www.ncbi.nlm.nih.gov/pubmed/27473059
http://dx.doi.org/10.1186/s12894-016-0165-3

Ejemplares similares